Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.

    Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, Vonderhaar BK.

    Breast Cancer Res. 2009;11(6):R82. Epub 2009 Nov 11.

    PMID:
    19906290
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.

    Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H.

    Breast Cancer Res. 2006;8(5):R59.

    PMID:
    17062128
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.

    Rappa G, Lorico A.

    Exp Cell Res. 2010 May 15;316(9):1576-86. Epub 2010 Jan 11.

    PMID:
    20074564
    [PubMed - indexed for MEDLINE]
    4.

    Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.

    Vesuna F, Lisok A, Kimble B, Raman V.

    Neoplasia. 2009 Dec;11(12):1318-28.

    PMID:
    20019840
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.

    Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, Lee EY, Chang KJ, Lee WH.

    PLoS One. 2009 Dec 21;4(12):e8377.

    PMID:
    20027313
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.

    Fillmore CM, Kuperwasser C.

    Breast Cancer Res. 2008;10(2):R25. Epub 2008 Mar 26.

    PMID:
    18366788
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Dynamic emergence of the mesenchymal CD44(pos)CD24(neg/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin).

    Oliveras-Ferraros C, Vazquez-Martin A, Martin-Castillo B, Cufí S, Del Barco S, Lopez-Bonet E, Brunet J, Menendez JA.

    Biochem Biophys Res Commun. 2010 Jun 18;397(1):27-33. Epub 2010 May 12.

    PMID:
    20470755
    [PubMed - indexed for MEDLINE]
    8.

    The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

    Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA, Polyak K.

    J Clin Invest. 2011 Jul;121(7):2723-35. doi: 10.1172/JCI44745.

    PMID:
    21633165
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

    Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.

    J Clin Pathol. 2011 Nov;64(11):937-46. Epub 2011 Jun 16.

    PMID:
    21680574
    [PubMed - indexed for MEDLINE]
    10.

    Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.

    D'Assoro AB, Leontovich A, Amato A, Ayers-Ringler JR, Quatraro C, Hafner K, Jenkins RB, Libra M, Ingle J, Stivala F, Galanis E, Salisbury JL.

    Int J Oncol. 2010 Nov;37(5):1167-76.

    PMID:
    20878064
    [PubMed - indexed for MEDLINE]
    11.

    [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].

    Li Z, Liu CP, He YL, Tian Y, Huang T.

    Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):547-9. Chinese.

    PMID:
    18798490
    [PubMed - indexed for MEDLINE]
    12.

    The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

    Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.

    Breast Cancer Res. 2008;10(3):R53. Epub 2008 Jun 17.

    PMID:
    18559090
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.

    Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL.

    Clin Exp Metastasis. 2009;26(5):433-46. Epub 2009 Feb 17.

    PMID:
    19221883
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.

    Tanaka H, Nakamura M, Kameda C, Kubo M, Sato N, Kuroki S, Tanaka M, Katano M.

    Anticancer Res. 2009 Jun;29(6):2147-57.

    PMID:
    19528475
    [PubMed - indexed for MEDLINE]
    15.

    Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

    Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW.

    J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52. Epub 2010 Jun 4. Review.

    PMID:
    20521089
    [PubMed - indexed for MEDLINE]
    16.

    [Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].

    Lu ZH, Jia J, Ren J, Ma B, DI LJ, Song GH.

    Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):480-5. Chinese.

    PMID:
    18931709
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

    Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y.

    BMC Cancer. 2010 Aug 10;10:414.

    PMID:
    20696077
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

    Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB.

    Cancer Res. 2010 Jan 15;70(2):709-18. Epub 2010 Jan 12.

    PMID:
    20068161
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.

    Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.

    Breast Cancer Res Treat. 2010 Jul;122(2):315-24. Epub 2009 Oct 1.

    PMID:
    19795205
    [PubMed - indexed for MEDLINE]
    20.

    Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.

    Zhang Y, Yao F, Yao X, Yi C, Tan C, Wei L, Sun S.

    Oncol Rep. 2009 Apr;21(4):1113-21.

    PMID:
    19288016
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk